about
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of ReportsAdverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South AfricaSerious adverse drug reactions at two children's hospitals in South AfricaA cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa
P50
Q34536677-09EC6B07-7F44-4D5D-8B7E-D078F6CA2EEBQ36125525-9B76C1A5-C9EE-47E4-AC70-781843987F08Q36289922-C383A131-B8E8-438E-AE8A-B0BD74AEF712Q36535205-8A52B720-5FF3-4AB4-B8AC-C030ED27B1EBQ36993353-B83F23CA-86A9-4075-B904-686A698A477DQ90027133-64B57414-EE5D-4865-A39D-890958A80439Q92413057-026A2221-CBEC-45B7-91D2-730FCF9F0385Q93031573-418E1FF3-E5B7-4E25-88B6-DF4DF09FD1AC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johannes P Mouton
@nl
Johannes P Mouton
@sl
Johannes P. Mouton
@en
Johannes P. Mouton
@es
type
label
Johannes P Mouton
@nl
Johannes P Mouton
@sl
Johannes P. Mouton
@en
Johannes P. Mouton
@es
prefLabel
Johannes P Mouton
@nl
Johannes P Mouton
@sl
Johannes P. Mouton
@en
Johannes P. Mouton
@es
P106
P1153
56709350000
P31
P496
0000-0002-3511-1259